Pepto-Bismol 262 mg/1
Bismuth subsalicylate · TABLET · ASCLEMED USA INC.
Pepto-Bismol is an over-the-counter oral tablet containing bismuth subsalicylate that is used to relieve symptoms of indigestion, heartburn, nausea, and diarrhea. This medication works by reducing inflammation in the stomach and intestines and has antimicrobial properties.
Key Facts
- Brand Name
- Pepto-Bismol
- Generic Name
- Bismuth subsalicylate
- NDC Code (Product)
76420-490- Manufacturer
- ASCLEMED USA INC.
- Strength
- 262 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- M008
- Drug Class
- Bismuth [EPC]
- Marketing Start
- 06/30/2004
Recall History
No Recall HistoryFrequently Asked Questions
What is Pepto-Bismol used for?
Pepto-Bismol is an over-the-counter oral tablet containing bismuth subsalicylate that is used to relieve symptoms of indigestion, heartburn, nausea, and diarrhea. This medication works by reducing inflammation in the stomach and intestines and has antimicrobial properties.
Is Pepto-Bismol a controlled substance?
Pepto-Bismol is not classified as a controlled substance by the DEA.
What is the generic name for Pepto-Bismol?
The generic name for Pepto-Bismol is Bismuth subsalicylate. There are 12 other brand versions of Bismuth subsalicylate.
What is the NDC code for Pepto-Bismol 262 mg/1?
The NDC (National Drug Code) for Pepto-Bismol 262 mg/1 is 76420-490, listed by ASCLEMED USA INC..
Other Bismuth Brands
See all →- AMAZON Regular Strength525 mg/30mL72288-706
- PEPT-ACHE262 mg/173598-1232
- Stomach Relief - Regular Strength525 mg/30mL76281-537
- Dye Free Regular Strength Stomach Relief525 mg/30mL79903-427
- Wonderbelly Multi-Symptom262 mg/182431-301
- Quality Choice Stomach Relief 528525 mg/15mL83324-021
- Revasol Peptic Relief525 mg/30mL84379-283
- Stomach Relief262 mg/185828-727
- Stomach Relief525 mg/30mL85828-791
- Rite Aid Regular Strngth Pink Bismuth525 mg/30mL11822-7016
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)